Gary C. Yee, Pharm.D., FCCP, BCOP
Gary C. Yee, Pharm.D., FCCP, BCOP

Professor and Associate Dean for Academic Affairs

College of Pharmacy
University of Nebraska Medical Center
986120 Nebraska Medical Center
Omaha, NE 68198-6120
402-559-2415 (Office)
402-559-5060 (Fax)
Email
 
Teaching Activities:
Dr. Yee gives lectures in several team-taught courses, including Pharmacotherapy IV (PHPR 678), Pharmaceutical Biotechnology (PHSC 520), and other courses taught at UNMC. Dr. Yee is the primary instructor and course coordinator for Drug Literature Evaluation and Research Methods (PHPR 622), which is based on the principles of Evidence-Based Medicine. Finally, he serves as one of the course coordinators for the Professional Development course (PHPR 554), which introduces and develops professional and leadership skills necessary to work as part of an interprofessional health care team.  Dr. Yee is one of the editors of Pharmacotherapy: A Pathophysiologic Approach, a textbook used in most Colleges of Pharmacy.

Service Activities: 
Dr. Yee has served as a member of guideline panels of several professional oncology groups, including the American Society of Clinical Oncology and National Comprehensive Cancer Network. He has also served as an elected officer in numerous professional organizations and served as President of the American College of Clinical Pharmacy from 2013 to 2014.

Research Activities/Interests: 
Dr. Yee's primary research interests are in the clinical pharmacology of drugs used in patients with cancer, particularly those undergoing hematopoietic stem cell transplantation. Other areas of interest include cost-effectiveness analysis, pharmacogenomics, biologic therapy, and targeted therapies. He has published more than 100 research articles, reviews, or book chapters, and his research findings have been published in several prominent journals, including the New England Journal of Medicine and the Lancet. 

Recent Publications: 

  1. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (eds.). Pharmacotherapy: A Pathophysiologic Approach, 9th edition, New York, McGraw-Hill, 2014.
  2. Poznak, CH, Temin S, Yee GC, et al. American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer. J Clin Oncol 2011; 29:1221-1229.
  3. Yee GC, Haas CE. Standards of practice for clinical pharmacists: the time has come. Pharmacotherapy 2014; 34:769-770.
  4. Hu M, Yee G, Zhou N, Yang N, Jiang X, Klepser D. Development and current status of clinical pharmacy education in China. Am J Pharm Ed 2014; 78:1-8 (article 157).